By Gina Shaw
With U.S. syphilis cases surging—they increased 80% between 2018 and 2022—a cross-governmental National Syphilis and Congenital Syphilis Syndemic Federal Task Force involving more than 200 members is focused on addressing the escalating epidemic in the face of drug shortages.
A Dec. 4, 2024 webinar featuring experts from the CDC, FDA, National Institutes of Health (NIH), and Department of Health and Human Services (HHS) highlighted treatment options in light of the